首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CURRENT PROBLEMS IN CANCER
ISSN：0147-0272

CURRENT PROBLEMS IN CANCER

CURR PROB CANCER
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：>12周，或约稿
新锐分区：医学3区
年发文量：52
影响因子：2.3
JCR分区：Q3

基本信息

《 当前 癌症 问题 》 旨在 促进 和 传播 以 患者 为 导向 的 癌症 研究 和 临床 护理 的 创新 、 变革 和 有 影响 力 的 数据 。具体 而言 ， 该 杂志 的 范围 集中 在 报告 精心 设计 的 癌症 研究 的 结果 ， 这些 研究 影响/改变 了 临床 癌症 研究 的 实践 或 确定 了 新 的 方向 。这些 研究 可以 包括 新 的 治疗 方法 、 早期 诊断 的 新 策略 、 癌症 临床 试验 和 支持 性 护理 等 。不 鼓励 只 关注 实验 室 或 基础 科学 研究 的 论文 。期刊 的 格式 有时 还 允许 通过 精选 的 综述 文章 对 单个 主题 进行 多 方面 的 概述 ， 同时 还 提供 影响 肿瘤 学 领域 的 动态 材料 。
0147-0272SCIE/Scopus收录
2.3
点击查看最新影响趋势>
2.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q3
208/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q3
202/328
29
52
点击查看年发文量趋势图>
20%较易>12周，或约稿-医学-肿瘤学
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
98.08%16.25%-
CiteScore：4.90
SJR：1.036
SNIP：0.761
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q2
161 / 415
大类：Medicine
小类：Cancer Research
Q3
126 / 233

期刊高被引文献

Metformin in breast cancer: preclinical and clinical evidence.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.06.003
Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.08.003
The possible role of insulin-like growth factor-1 in osteosarcoma.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.08.008
A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.02.002
Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.04.005
Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.06.001
Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.07.003
Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.05.006
Outcome comparisons of high-grade glioma resection with or without fluorescein sodium-guidance.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.07.007
Future directions in soft tissue sarcoma treatment.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.06.004
Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.08.005
Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.12.004
Causal effect of obesity on gynecologic malignancies.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.07.011
Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.07.005
Pericardial effusion due to pembrolizumab-induced immunotoxicity: A case report and literature review.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.01.001
Portal vein stent for symptomatic malignant portal vein stenosis: A single-center experience.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.04.002
Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
来源期刊：Current problems in cancerDOI：10.1016/J.CURRPROBLCANCER.2019.100516
Brigatinib: New-generation ALK inhibitor for nonsmall cell lung cancer.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.03.005
Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.01.009
NAT10 upregulation indicates a poor prognosis in acute myeloid leukemia.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.06.006
Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100513
Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.01.002
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.01.008
Vitamin D deficiency in cancer patients and predictors for screening (D-ONC study).
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.12.008
Contemporary management of metastatic soft tissue sarcoma.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.06.005
Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: An exploratory study.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100510
Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100502
Burnout Among oncologists in the Republic of Korea: A nationwide survey.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100535
The role of histopathologic testing on apocrine carcinoma of the breast.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100501
Association of lymphadenectomy and survival in epithelial ovarian cancer.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.08.002
Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.05.003
The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100514
Insurance status is related to overall survival in patients with small intestine adenocarcinoma: A population-based study.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100505
The diagnostic and prognostic roles of serum irisin in bladder cancer.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100529
Alterations in XRCC1 gene profile in pathogenesis of oral cavity cancer: A population-based study from Kamrup Urban District of Assam, India.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.03.003
What is the real prognostic value of close margins in oral oncology?
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100500
Involved-field irradiation for elderly bladder cancer patients.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.07.009
Prevalence of bone pain decreases as lymph node stage increases in nonsmall cell lung cancer patients.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.08.006
Axillary web syndrome: Incidence, pathogenesis, and management.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.02.002
Breast cancer after multiple myeloma treatment.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.01.004
Atypical PRES with diffusion restriction or neurotoxicity- ? part of same spectrum-after oxaliplatin (FOLFOX-4 regimen) for colonic cancer.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.04.004
Hopelessness is associated with poor sleep quality after breast cancer surgery among Tunisian women.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100504
Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: Case report and review of the literature.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2018.12.007
Uterine sarcomas.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.06.001
Efficacy of zoledronic acid for prevention of bone loss in early-stage breast cancer patients receiving adjuvant therapy: A meta-analysis of 13 randomized controlled trials.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100507
A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update.
来源期刊：Current problems in cancerDOI：10.1016/J.CURRPROBLCANCER.2019.06.007
Factors associated with mortality from lung cancer in India.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.100512
Effect of clinicopathologic features on survival of patients with thymic carcinomas and thymic neuroendocrine tumors: A population-based analysis.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.03.004
Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia.
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.05.004
Radiological and histological findings of an asymptomatic ever-increasing neoplasm: The small bowel neuroendocrine tumor (NET).
来源期刊：Current problems in cancerDOI：10.1016/j.currproblcancer.2019.07.001

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
否